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Introduction
Noninvasive imaging of atherosclerosis may benefit from
the characterization of plaque biological activity. Macro-
phages are ideal targets as they have a critical role in pro-
gression of atherosclerotic lesions. Novel graphite/metal
core-shell nanocrystals (CN) show promising properties
as MRI contrast agents for cellular imaging [1].
Purpose
To evaluate 1) CN uptake by macrophages in vitro, and 2)
CN uptake in mouse atherosclerotic lesions in vivo.
Methods
Graphite/Metal core-shell nanocrystals
CN are composed of an Fe/Co core with a carbon graphite
shell and phospholipid-polyethylene glycol molecules,
with Cy5.5 attached for in vivo experiments.
In Vitro Uptake/Imaging
Mouse macrophage cells (RAW264) were incubated with
ferumoxytol (Feridex), ferumoxtran-10 (Combidex), or
graphite/metal core-shell nanocrystals (CN) for 24 hours,
each at a concentration of 100 ugFe/ml. After incubation,
5 × 106 cells from each group were scanned by MRI at 1.5
T (GE Healthcare, Milwaukee, WI) to examine cellular
uptake of contrast using a standard gradient echo
sequence (TR/TE = 100/10, FA = 30, Matrix = 256 × 256,
slice thickness = 2.0, FOV = 12 cm).
In Vivo Uptake/Imaging
FVB mice (N = 5) underwent a carotid-ligation procedure
previously shown to produce a macrophage-rich athero-
sclerotic lesion. Briefly, they were given high fat diet for 4
weeks and then had diabetes induced by 5 daily intraperi-
toneal injections of streptozotocin. After 2 weeks of diabe-
tes, carotid ligation of the left carotid artery was
performed. Two weeks post carotid ligation, mice were
given CN-Cy5.5 (8 nmol of Cy5.5) via tail vein and
scanned serially over 12–48 hours using the Maestro in-
vivo fluorescent imaging system (CRI, Woburn, MA). After
final in vivo imaging, carotid arteries were exposed and
both in situ and ex vivo imaging were performed.
Results
In vitro CN uptake by macrophages was clearly seen by
T2*-weighted MRI. The area of signal loss was signifi-
cantly greater (p < 0.001, Figure 1) for CN than ferumox-
tran-10 (Combidex; common in vivo macrophage imaging
agent). However, the uptake of CN in vitro was less than
ferumoxytol (Feridex; common in vitro stem cell labeling
agent).
In vivo fluorescence imaging showed limited carotid sig-
nal, but both in situ and ex vivo fluorescence imaging at
12–48 hours showed high signal from the ligated left
carotid, confirming in vivo CN uptake in the atheroscle-
rotic lesions (Figure 2). No evidence of CN accumulation
was seen in the non-ligated right carotid arteries.
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The novel CN contrast agent was effectively taken up by
macrophages in vitro and by macrophage-rich atheroscle-
rotic lesions in vivo. Further development of in vivo MRI
and fluorescence imaging of graphite/metal core-shell
nanocrystals may allow direct noninvasive detection of
vascular inflammation.
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